Navigation Links
Top Ten Pharma Company Deploys MedNet Solutions' Investigator Initiated Trial Management System
Date:3/19/2009

MINNETONKA, Minn., March 19 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, today announced that one of the world's largest pharmaceutical companies has deployed MedNet's Investigator Initiated Trial (IIT) Management System. This system provides a powerful, flexible and efficient solution to manage the entire IIT lifecycle... from proposal to publication... helping to ensure comprehensive, standardized and auditable IIT submissions, decisions and tracking on a world-wide basis.

"We are extremely pleased that MedNet has been selected to deliver the vital technology infrastructure required to fully automate, centralize and streamline the international IIT management processes of this industry leading pharmaceutical organization," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We believe this selection validates MedNet's continued commitment to providing the high level of expertise, technology and support needed to help life sciences organizations achieve operational efficiencies in all aspects of clinical research."

The MedNet IIT Management System delivers robust, highly configurable capabilities that allow pharmaceutical, medical device and biotechnology companies to achieve global IIT management standardization, increased IIT visibility, and reduced IIT program related time and cost expenditures. The solution also delivers the tools needed to shorten timelines from concept submission to publication, minimize redundant studies, and enhance investigator and management satisfaction.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology, and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit www.mednetstudy.com.

    Contact Information:
    Dirk H. Nelson
    Marketing Manager
    601 Carlson Parkway, Suite 605
    Minnetonka, MN  55305
    USA
    (763) 258-2735


'/>"/>
SOURCE MedNet Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
2. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
3. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
4. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy
5. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
6. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
7. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
8. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
9. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
10. Helix BioPharma Announces Q2 2009 Financial Results
11. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):